Kaken Pharmaceutical Co., Ltd.

OTCPK:KKPC.F Stock Report

Market Cap: US$1.1b

Kaken Pharmaceutical Future Growth

Future criteria checks 0/6

Kaken Pharmaceutical's revenue and earnings are forecast to decline at 8.6% and 56.2% per annum respectively. EPS is expected to decline by 56.2% per annum. Return on equity is forecast to be 1.6% in 3 years.

Key information

-56.2%

Earnings growth rate

-56.2%

EPS growth rate

Pharmaceuticals earnings growth23.9%
Revenue growth rate-8.6%
Future return on equity1.6%
Analyst coverage

Low

Last updated19 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

OTCPK:KKPC.F - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202767,9502,9806,0385,7382
3/31/202669,6003,00512,02510,1382
3/31/202588,40015,130-3,27714,1252
9/30/202487,24518,24323,48526,754N/A
6/30/202472,1487,269N/AN/AN/A
3/31/202472,0448,0254102,577N/A
12/31/202372,0962,966N/AN/AN/A
9/30/202372,3363,5447142,581N/A
6/30/202372,9375,043N/AN/AN/A
3/31/202372,9845,4407,0479,253N/A
12/31/202273,8998,452N/AN/AN/A
9/30/202275,2658,79211,47814,329N/A
6/30/202275,7789,094N/AN/AN/A
3/31/202276,0349,54910,07913,336N/A
12/31/202175,60512,717N/AN/AN/A
9/30/202175,77812,90010,13413,123N/A
6/30/202175,36212,947N/AN/AN/A
3/31/202174,97913,40512,09414,380N/A
12/31/202076,13614,750N/AN/AN/A
9/30/202080,85117,04916,65818,502N/A
6/30/202084,96718,364N/AN/AN/A
3/31/202089,23219,37025,26627,468N/A
12/31/201991,75919,082N/AN/AN/A
9/30/201991,81418,48227,06529,746N/A
6/30/201992,36518,566N/AN/AN/A
3/31/201994,16517,77519,00121,129N/A
12/31/201894,12316,431N/AN/AN/A
9/30/201896,09117,01515,60717,657N/A
6/30/201897,59817,615N/AN/AN/A
3/31/201898,43019,043N/A21,703N/A
12/31/201799,40520,893N/AN/AN/A
9/30/201799,16021,439N/A20,714N/A
6/30/2017100,21821,684N/AN/AN/A
3/31/2017101,47922,017N/A15,327N/A
12/31/2016103,26418,992N/AN/AN/A
9/30/2016106,93620,106N/A22,215N/A
6/30/2016108,32520,639N/AN/AN/A
3/31/2016109,73021,143N/A27,067N/A
12/31/2015108,16522,651N/AN/AN/A
9/30/2015104,63018,966N/A22,113N/A
6/30/2015100,05815,792N/AN/AN/A
3/31/201593,88912,122N/A14,737N/A
12/31/201493,08311,909N/AN/AN/A
9/30/201489,46610,776N/A10,586N/A
6/30/201489,14010,158N/AN/AN/A
3/31/201488,9469,735N/A13,663N/A
12/31/201387,2679,042N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: KKPC.F's earnings are forecast to decline over the next 3 years (-56.2% per year).

Earnings vs Market: KKPC.F's earnings are forecast to decline over the next 3 years (-56.2% per year).

High Growth Earnings: KKPC.F's earnings are forecast to decline over the next 3 years.

Revenue vs Market: KKPC.F's revenue is expected to decline over the next 3 years (-8.6% per year).

High Growth Revenue: KKPC.F's revenue is forecast to decline over the next 3 years (-8.6% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: KKPC.F's Return on Equity is forecast to be low in 3 years time (1.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y